These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15715354)

  • 1. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leukopenia with unclear fever].
    Mayer S; Kündiger T; Schrader H
    Internist (Berl); 2017 Jul; 58(7):740-744. PubMed ID: 28265684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agranulocytosis in a patient treated with metamizole and clopidogrel].
    Kummer O; Haschke M; Tuchscherer D; Lampert M; Martius F; Krähenbühl S
    Praxis (Bern 1994); 2006 Nov; 95(45):1743-5; quiz 1746-7. PubMed ID: 17205929
    [No Abstract]   [Full Text] [Related]  

  • 4. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking of Metamizole-induced Liver Injury by Simult aneous Development of Characteristic Agranulocytosis.
    Lutz M; Grünewald I; Lenze F; Heinzow H; Ullerich H; Kabar I; Schmidt HH; Tepasse PR
    Curr Drug Saf; 2023; 18(3):404-412. PubMed ID: 35670337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor (G-CSF) in a surgical intensive care unit].
    Huss B; Bogosyan S; Müller E; Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):529-30. PubMed ID: 9019189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agranulocytosis caused by metamizol. Anesthetic attitude].
    Prieto Alvarez MP; Fuentes Bellido JG; López Cebollada J; Escoda Teigell L; Lorenzo Foz JP
    Rev Esp Anestesiol Reanim; 1998; 45(6):248-50. PubMed ID: 9719723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyrone-induced granulocytopenia: a case for awareness.
    Garcia S; Canionero M; Lopes G
    Pharmacotherapy; 2006 Mar; 26(3):440-2. PubMed ID: 16503727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening bite injury of the lower lip after use of metamizole.
    Becker ST; Wiltfang J; Springer IN; Bartsch MS; Guenther R; Sherry E; Warnke PH
    Oral Maxillofac Surg; 2008 May; 12(1):39-41. PubMed ID: 18600360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL; Ibáñez Camacho MF; López Pérez E
    Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis].
    Send T; Westermann S; Eichhorn KW; Jakob M
    HNO; 2015 Mar; 63(3):215-9. PubMed ID: 25515122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dual agranulocytosis episode likely resulting from metamizole use].
    Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
    Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
    [No Abstract]   [Full Text] [Related]  

  • 16. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).
    Willfort A; Lorber C; Kapiotis S; Sertl S; Hainz R; Kirchweger P; Jäger U; Kyrle PA; Lechner K; Geissler K
    Ann Hematol; 1993 May; 66(5):241-4. PubMed ID: 7685193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis from metamizole: a potential problem for the British population].
    Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
    Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.